Block A, Phase III, PO. Kalyani, Dist. Nadia, West Bengal - 741235 +91 62923 41931 info.jip@jisgroup.org

Research Projects & Publications

Pioneering Pharmaceutical Research

Driving Healthcare Innovation Through Scientific Inquiry

Faculty members and student researchers at JIS Institute of Pharmacy (JISIP) are actively engaged in translational pharmaceutical sciences—spanning nanotechnology-based drug delivery, in-silico computer-aided drug design, phytochemistry, and clinical antimicrobial stewardship. Our findings are published across globally respected journals indexed in Scopus, Web of Science, and PubMed.

10+
Peer-Reviewed Papers
Elsevier, Wiley, Taylor & Francis, CSIR & Innovare
Q1 / Scopus
High-Impact Journals
Nanomedicine NBM, Chemistry & Biodiversity, IJNPR
4
Specialized Domains
Nanocarriers, In-Silico Design, Phytochemistry & AMR
100%
Collaborative Research
Inter-institutional projects with JIS University & GNIPST
Green Synthesis and Antibacterial Potential of Silver Nanoparticles from Typhonium trilobatum
Preview Document
Research / Conference Article Innovare Academic Sciences JIS University Collaboration Green Nanotechnology Published 2025

Green Synthesis and Antibacterial Potential of Silver Nanoparticles from Typhonium trilobatum

Authors: Srijan Panigrahi*, Ritu Khanra
Journal: International Journal of Applied Pharmaceutics, Vol 17, Issue 1, 2025 (ISSN: 0975-7058, JISUCONPH2024/PC/PP029)
Affiliation: Department of Pharmaceutical Technology, JIS University, Kolkata-700109, West Bengal, India
Abstract & Research Highlights:

Green synthesis of metallic nanoparticles has gained significant attention due to its cost-effectiveness, simplicity, and environmental compatibility. Typhonium trilobatum, a small tuberous herb from the family Araceae, was investigated in this study for its phytochemical and antioxidant properties and as a source for green-synthesized silver nanoparticles (AgNPs). Phytochemical screening revealed the presence of flavonoids, alkaloids, steroids, triterpenoids, and tannins. High-Performance Thin-Layer Chromatography (HPTLC) identified three polyphenolic compounds—chlorogenic acid, kaempferol, and caffeic acid. AgNPs exhibited spherical morphology with mean particle size of 290.5 nm, zeta potential of -12.3 mV, and strong antibacterial activity against both Bacillus subtilis (ATCC-6633) and Escherichia coli (ATCC-8739).

Keywords: Typhonium trilobatum Green Synthesis Silver Nanoparticles Antioxidant Activity Antibacterial Potential
In-Silico Structure-Based Design of a Phytoconstituent Derived DENV2 NS5 RdRp Inhibitor
Preview Document
Original Research Article Biointerface Research in Applied Chemistry Aniruddha Sarkar (JISIP) Antiviral Drug Discovery Published 2026

In-Silico Structure-Based Design of a Phytoconstituent Derived DENV2 NS5 RdRp Inhibitor

Authors: Amitesh Chakraborty, Santanu Giri, Shubhadeep Hazra, Aniruddha Sarkar, Tushar Adhikari*
Journal: Biointerface Research in Applied Chemistry, Vol 16, Issue 2, 2026, Article 58 (ISSN: 2069-5837)
Affiliation: Department of Pharmacy, JIS Institute of Pharmacy, Kalyani, West Bengal 741235, India; Flemming College; DmbH Institute; GNIPST
Abstract & Research Highlights:

Dengue fever, an Aedes mosquito-borne disease caused by the Dengue virus (DENV), currently lacks an FDA-approved drug. One key enzyme involved in dengue virus replication is the NS5 RNA-dependent RNA polymerase (RdRp) protein. This research focuses on identifying and designing a novel inhibitor of NS5 RdRp (PDB ID: 6IZY) of DENV2 through the screening of phytoconstituents using in-silico approaches. The compound 2-allyl-1-amino-7,7-dimethyltetradecahydro-5H-pyrrolo[2',1':2,3]pyrimido[6,1-a]isoquinoline-3,8,9-triol was designed and found to exhibit favorable docking interactions at the palm domain of RdRp with high predicted safety (LD50 = 3500 mg/kg), wide therapeutic index, and favorable pharmacokinetic safety.

Keywords: Dengue DENV NS5 RdRp Molecular Docking Pharmacophore QSAR
View Official DOI Article
Homology Modeling and Pharmacophore Based Inhibitor Design Targeting Isocitrate Lyase of Madurella mycetomatis – A Novel Approach Against Eumycetoma
Preview Document
Original Research Article Wiley-VHCA (Chemistry & Biodiversity) Aniruddha Sarkar (JISIP) Neglected Tropical Diseases Published 2026

Homology Modeling and Pharmacophore Based Inhibitor Design Targeting Isocitrate Lyase of Madurella mycetomatis – A Novel Approach Against Eumycetoma

Authors: Santanu Giri, Shubhadeep Hazra, Amitesh Chakraborty, Aniruddha Sarkar, Tushar Adhikari*
Journal: Chemistry & Biodiversity, 2026, 23:e03766 (Wiley-VHCA AG)
Affiliation: Department of Pharmacy, JIS Institute of Pharmacy, Kalyani, West Bengal, India; DmbH Institute; Flemming College; GNIPST
Abstract & Research Highlights:

Eumycetoma, caused by pathogenic fungi, is one of the most neglected tropical diseases worldwide. The causative agent Madurella mycetomatis uses isocitrate lyase (ICL) to promote gluconeogenesis for growth and survival in adverse host conditions. Homology modeling was used to predict the 3D structure of ICL using Magnaporthe oryzae as a template (85.80% similarity). A dataset of 100 unique phytochemicals were screened, followed by pharmacophore modeling, scaffold optimization, QSAR analysis, retrosynthetic feasibility, and molecular dynamics simulations demonstrating high structural stability and competitive enzyme inhibition.

Keywords: Eumycetoma Granuloma Homology Modeling Isocitrate Lyase Madurella mycetomatis
View Official DOI Article
Quantitative Analysis of Phytoconstituents and in-vitro Biological Activities of Nine Edible Microgreens from West Bengal
Preview Document
Original Research Article CSIR-NIScPR Aniruddha Sarkar (JISIP) Nutraceuticals & Antioxidants Published 2025

Quantitative Analysis of Phytoconstituents and in-vitro Biological Activities of Nine Edible Microgreens from West Bengal

Authors: Amitesh Chakraborty, Aniruddha Sarkar, Shubhadeep Hazra, Santanu Giri, Priya Bardhan Ray, Tushar Adhikari*
Journal: Indian Journal of Natural Products and Resources, Vol 16(4), Dec 2025, pp. 605-619
Affiliation: Department of Pharmaceutical Chemistry, JIS Institute of Pharmacy, Kalyani, West Bengal 741235; GNIPST; Flemming College; DmbH Institute
Abstract & Research Highlights:

Microgreens are promising sources of nutrition and bioactives. This study quantified total phytoconstituent content and determined in vitro anti-oxidant, anti-diabetic, and anti-inflammatory activities of nine microgreens: chia, coriander, carrot, fenugreek, radish, spinach, sunflower, turnip, and beetroot. Sunflower microgreen proved to be the most potent antioxidant (IC50 = 48.19 µg/mL). Fenugreek demonstrated potent alpha-amylase inhibitory activity (IC50 = 11.01 µg/mL). Chia and coriander were promising anti-inflammatory agents (IC50 = 23.09 and 28.40 µg/mL), highlighting their therapeutic application as functional foods.

Keywords: Alpha-amylase inhibition DPPH scavenging Microgreens Functional Foods Phytoconstituents
View Official DOI Article
Unripe Fruits Found as Sources of Bioactive Compounds: A New Frontier in Drug Discovery
Preview Document
Review Article Visagaa Publishing House Aniruddha Sarkar (JISIP) Phytochemical Drug Discovery Published 2026

Unripe Fruits Found as Sources of Bioactive Compounds: A New Frontier in Drug Discovery

Authors: Amitesh Chakraborty, Santanu Giri, Shubhadeep Hazra, Aniruddha Sarkar, Parnasree Chakraborty, Tushar Adhikari*
Journal: Natural Resources for Human Health, 2026; 6(1): 190–210 (eISSN: 2583-1194)
Affiliation: Department of Pharmaceutical Chemistry, JIS Institute of Pharmacy, Kalyani, West Bengal 741235; Flemming College; DmbH Institute; GNIPST
Abstract & Research Highlights:

In the era where synthetic compounds are being complemented by natural remedies, unripe fruits represent an unexplored treasure trove for drug development. Unripe fruits maintain greater secondary metabolite profiles for self-defense. This comprehensive review analyzes literature from 1990 to present, detailing high ascorbic acid and polyphenols in unripe amla (Phyllanthus emblica) and Bengal lemon (Citrus limon), antimicrobial peptides (CnAMPs) in tender coconut water, and potent anti-inflammatory atrocarpin in unripe jackfruit and green peas.

Keywords: Antioxidant Antimicrobial Bioactive Compounds Phytochemistry Unripe Fruits
View Official DOI Article
Formulation and in vitro Characterisation of Atenolol Transdermal Film with Natural Polysaccharide
Preview Document
Original Research Article Innovare Academic Sciences Swarnim Gupta (JISIP) Abhishek Jana (JISIP) Debarati Kar (JISIP) Prof. Pintu Kumar De (JISIP) Published 2025

Formulation and in vitro Characterisation of Atenolol Transdermal Film with Natural Polysaccharide

Authors: Swarnim Gupta, Rima Dawn, Abhishek Jana, Debarati Kar, Tathagata Roy, Pintu Kumar De*
Journal: International Journal of Applied Pharmaceutics, Vol 17, Issue 6, 2025 (ISSN: 0975-7058)
Affiliation: JIS Institute of Pharmacy, Kalyani, Nadia, West Bengal-741235, India; Department of Pharmaceutical Technology, JIS University, Kolkata; NSHM Knowledge Campus
Abstract & Research Highlights:

Novel controlled-release transdermal drug delivery systems (TDDS) containing atenolol were developed using eco-friendly natural polysaccharides to improve patient compliance and reduce cardiovascular side effects. Chia seed mucilage (CSM) and carboxymethylated chia seed mucilage (CCSM) were blended with HPMC and plasticizers via solvent evaporation. The films demonstrated high folding endurance (>120), uniform thickness (0.0546–0.073 mm), drug content between 96% and 98%, and sustained cumulative drug release of 35.26% and 34.27% at 480 min.

Keywords: Transdermal Drug Delivery (TDDS) Chia Seed Mucilage (CSM) Atenolol HPMC Controlled Drug Release
View Official DOI Article
Formulation and Comparative Evaluation of Allopurinol Transdermal Patches Using Two Different Polymeric Combinations
Preview Document
Research Article Journal of Applied Pharmaceutical Research (JOAPR) Abhishek Jana (JISIP) Swarnim Gupta (JISIP) Prof. Pintu Kumar De (JISIP) Published 2026

Formulation and Comparative Evaluation of Allopurinol Transdermal Patches Using Two Different Polymeric Combinations

Authors: Adity Modak, Tiyash Roy, Abhishek Jana, Swarnim Gupta, Pintu Kumar De*
Journal: Journal of Applied Pharmaceutical Research, Vol 14, Issue 3, Year 2026, pp. 345–354 (ISSN: 2348-0335)
Affiliation: JIS Institute of Pharmacy, Kalyani, Nadia, West Bengal-741235, India; Department of Pharmaceutical Technology, JIS University, Kolkata; Dr. Sudhir Chandra Sur Institute
Abstract & Research Highlights:

The transdermal drug delivery system offers several therapeutic benefits over oral administration by bypassing hepatic first-pass metabolism and minimizing gastric irritation. In this study, matrix-type transdermal patches of Allopurinol (xanthine oxidase inhibitor for hyperuricemia and gout) were prepared using hydrophilic polymers (PEG-4000 and HPMC) and hydrophobic ethyl cellulose (EC). Drug release studies demonstrated 59.43% release in 5 h (EC:PEG-4000 2:1) and 57.28% in 5 h (EC:HPMC 2:1) with outstanding physical stability and controlled permeation kinetics.

Keywords: Allopurinol Transdermal Patches Gout Hydrophilic Polymer Controlled Release
View Official DOI Article
Cutting-edge Strategies for Delivering Drugs to the Brain Based on Nanocarriers
Preview Document
Review Article Taylor & Francis (Informa UK) Abhishek Jana (JISIP) Brain Targeted Drug Delivery CNS Disorders Published 2025

Cutting-edge Strategies for Delivering Drugs to the Brain Based on Nanocarriers

Authors: Tapan Kumar Shaw, Saikat Mollick Shuvo, Paramita Paul, Abhishek Jana, Kazi Asraf Ali*
Journal: Drug Development and Industrial Pharmacy, Taylor & Francis Online
Affiliation: Department of Pharmaceutics, JIS Institute of Pharmacy, Kalyani; JIS University; University of North Bengal; MAKAUT
Abstract & Research Highlights:

Central nervous system (CNS) disorders (Alzheimer's, Parkinson's, epilepsy, dementia, stroke, and brain malignancies) represent a major global health challenge due to the physiological impermeability of the Blood-Brain Barrier (BBB). This review critically investigates nanotechnology-integrated delivery systems including liposomes, solid lipid nanoparticles, dendrimers, polymeric nanoparticles, exosomes, and ligand-functionalized delivery vectors designed to facilitate non-invasive transport across the BBB and minimize systemic toxicity.

Keywords: Neurological Disorders Blood-Brain Barrier (BBB) Nanocarriers Brain Targeting Central Nervous System
View Official DOI Article
Design and Optimization of Diacerein Loaded Lipid Nanocarriers: Characterization, in vitro and in vivo Evaluation for Anti-Arthritic Activity
Preview Document
Research Article Elsevier (Nanomedicine: NBM) Abhishek Jana (JISIP) Elsevier Scopus Q1 Anti-Arthritic SLNPs Published 2026

Design and Optimization of Diacerein Loaded Lipid Nanocarriers: Characterization, in vitro and in vivo Evaluation for Anti-Arthritic Activity

Authors: Swarupananda Mukherjee*, Priya Ghosh, Saheli Naskar, Iman Ehsan, Tathagata Roy, Ayon Dutta, Susanta Paul, Abhishek Jana, Dipanjan Karati, Abhik Paul, Dipanjana Ash
Journal: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol 73, 2026, Article 102914 (Elsevier)
Affiliation: Department of Pharmaceutics, JIS Institute of Pharmacy, Kalyani, West Bengal; NSHM; Sister Nivedita University; Brainware; Techno India; BCDA College
Abstract & Research Highlights:

Diacerein (BCS class II anti-arthritic drug) suffers from poor aqueous solubility and low oral bioavailability (35–56%). In this study, Diacerein-loaded solid lipid nanoparticles (DC-SLNPs) were engineered via solvent evaporation and optimized using a 3^2 full factorial design. Optimized DC-SLNPs demonstrated narrow particle size (303 ± 0.78 nm), high entrapment efficiency (79.5 ± 0.5%), and drug content (88.59 ± 0.6%). Significant reduction in LPS-induced inflammatory stress on RAW 264.7 macrophage cells and superior in-vivo anti-arthritic efficacy were demonstrated.

Keywords: Anti-arthritic Diacerein RAW 264 Solid Lipid Nanoparticles Factorial Design
View Official DOI Article
“Awareness is the Way to Resistance”: Role of Pharmacist in Combating Antibiotic Resistance of Public Health
Preview Document
Journal / Review Article International Journal on Science and Technology Sayantan Bhattacharya (JISIP) Megha Bhowmick (JISIP Student/Researcher) Antimicrobial Stewardship Published 2026

“Awareness is the Way to Resistance”: Role of Pharmacist in Combating Antibiotic Resistance of Public Health

Authors: Ms. Sumona Khatun, Mrs. Rupa Yasmin, Ms. Anwesha Naskar, Mr. Sayantan Bhattacharya, Ms. Megha Bhowmick
Journal: International Journal on Science and Technology (IJSAT), Vol 17, Issue 2, April–June 2026 (E-ISSN: 2229-7677)
Affiliation: JIS Institute of Pharmacy, Phase III, Block A, Kalyani, West Bengal-741235; Flemming College of Pharmacy, Kolkata
Abstract & Research Highlights:

Antimicrobial resistance (AMR) is one of the most serious public health emergencies of our time, threatening the efficacy of modern healthcare treatments. Irrational and excessive use of antibiotics, incomplete regimens, and over-the-counter dispensing without prescription accelerate resistant pathogens. This study synthesizes WHO policies and clinical literature, demonstrating the indispensable frontline role of pharmacists in rational antibiotic dispensing, patient counseling, community education, and institutional antimicrobial stewardship programs.

Keywords: Antibiotic Resistance Antimicrobial Resistance (AMR) Public Health Role of Pharmacists Antimicrobial Stewardship
Scholarly Distinctions & Academic Honors

Faculty Conference Chairs, Awards & Scientific Posters

Beyond journal publications, JISIP faculty members regularly chair national conference sessions, lead technical symposiums, and earn international recognition for pharmaceutical research.

International Research Star Award 2024
Zoom

International Research Star Award 2024

Ms. Debarati Kar (Assistant Professor, JISIP)
International Research Awards and Congress 2024 (IIRAC 2024) (June 23, 2024 | Hotel Breeze Residency)

Honored with the prestigious International Research Star Award for outstanding research contributions and academic excellence in the domain of Pharmacology and novel therapeutics.

Session Chairperson — TIU National Seminar
Zoom

Session Chairperson — TIU National Seminar

Prof. Pintu Kumar De (Principal, JISIP)
National Seminar on "Current Scenario of Pharmaceutical Technology: Academia to Industry", Techno India University (September 20, 2023)

Chaired the technical keynote session delivered by Prof. (Dr.) Biswajit Mukherjee (Jadavpur University) addressing translational research and industrial technology transfer.

Keynote Session Chair — JISU-Pharmanecia 2K23
Zoom

Keynote Session Chair — JISU-Pharmanecia 2K23

Prof. Pintu Kumar De (Principal, JISIP)
1st National Conference of JISU-PHARMANECIA 2K23, JIS University (September 19-20, 2023)

Chaired the distinguished keynote address delivered by Dr. Swati Biswas (Professor, Department of Pharmacy, BITS Pilani Hyderabad) on advanced nanocarrier therapeutics.

Academic Poster Presentation — JISU-PHARMANECIA
Zoom

Academic Poster Presentation — JISU-PHARMANECIA

Mr. Abhishek Jana (Assistant Professor, JISIP)
National Conference on "Advanced Therapeutics for Life-Threatening and Chronic Diseases" (September 19-20, 2023)

Presented scientific poster on formulation optimization of lipid nanocarriers and targeted delivery platforms for chronic diseases.

National Education Policy (NEP 2020) Poster
Zoom

National Education Policy (NEP 2020) Poster

Ms. Swarnim Gupta (Assistant Professor, JISIP)
National Conference on "Transforming Pharmacy Education as per NEP 2020", Brainware University (August 25-26, 2023)

Presented research paper on integrating competency-based pharmaceutical training, natural polymer excipients, and holistic learning frameworks.

Patient Safety Research Presentation
Zoom

Patient Safety Research Presentation

Ms. Debarati Kar (Assistant Professor, JISIP)
National Seminar on "Role of Pharmacists in Patient Safety", Indian Pharmaceutical Association (Bengal Branch) (November 25, 2023)

Scientific poster presentation addressing medication error prevention, clinical pharmacovigilance, and the community pharmacist's role in patient wellness.

Research Collaborations & Institutional Tie-Ups

JISIP actively collaborates with research universities, hospital centers, and formulation companies for joint projects, clinical trials, and student internships.

Connect for Research Collaboration